In a finding that could have implications for leukemia treatment, investigators at the University of California, San Diego School of Medicine have linked a protein associated with an important stem cell signal to cancer growth.
An international team of scientists has found a new way to create stem cells without the use of an embryo or outside DNA--an advance in stem cell technology that doesn't carry the ethical concerns of embryonic stem cells or the safety issues of induced pluripotent stem cells.
The California Institute for Regenerative Medicine is putting $40 million toward the creation of a new Center of Excellence in Stem Cell Genomics, which will bring together experts and investigators from 7 California institutions.
Johns Hopkins researchers have developed a safer way to make human iPS cells, and using these cells, they've successfully repaired damaged retinal vascular tissue in mice.
Knowing how to preserve human embryonic stem cells in their pluripotent state until they are needed will help scientists better harness these cells for use in a variety of therapies. Now researchers have identified a gene receptor and signaling pathway that plays an essential role in preserving hESCs in an undifferentiated state.
International Stem Cell Corp. has found a new way to genetically reprogram mature cells into an embryonic-like state, a technique the Carlsbad, CA-based company believes is a safer and more efficient way of creating induced pluripotent stem cells.
Using stem cell technology, Johns Hopkins researchers and collaborators at Isis Pharmaceuticals have developed several new compounds that seem to halt the toxic effects that lead to brain destruction in amyotrophic lateral sclerosis and dementia in lab studies.
Using cell material from mice, an international team led by researchers at the University of Copenhagen's Danish Stem Cell Center has developed a way to grow a miniature 3-D pancreas.
Combining gene therapy plus an infusion of stem cells helps heal wounds faster in mice, a discovery that could eventually lead to better treatments for older people with wounds, who fail to heal as well as younger patients.
The outlook for young patients diagnosed with medulloblastoma is grim. The highly malignant brain tumor mostly affects children, and treatments are aggressive, often leaving patients with severe side effects, such as lowered IQ levels and increased susceptibility to other cancers.